Results for tag: "Gattex"

Gattex is a brand of gastrointestinal drug used to treat short bowel syndrome (SBS). It is a recombinant human glucagon-like peptide-2 (GLP-2) analog, which helps to increase the absorption of nutrients in the small intestine. Gattex is administered as a subcutaneous injection and is the only approved treatment for SBS in the United States. Gattex is a relatively new drug, having been approved by the U.S. Food and Drug Administration (FDA) in 2012. It is manufactured by NPS Pharmaceuticals, Inc., and is marketed in the United States by Shire plc. The Gattex market is a small but growing segment of the gastrointestinal drug market. It is a niche market, with only a few companies offering products for SBS. These companies include NPS Pharmaceuticals, Shire plc, and Takeda Pharmaceuticals. Show Less Read more